Hikma Pharmaceuticals

#News for #media and #investors We are proud to announce the signing of a strategic Memorandum of Understanding (MoU) with M42 Health at Arab Health 2025. This collaboration strengthens our efforts in promoting Shield™, a US FDA-approved, non-invasive blood test for colorectal cancer screening. This MoU supports healthcare #innovation in the #UAE through more precise, preventive, and predictive cancer care programmes, using cutting-edge genomics technology for early cancer detection, to improve treatment outcomes. Read the full press release: https://lnkd.in/d7z95ysB #BetterHealth #WithinReach #EveryDay #Oncology #PrecisionMedicine Picture 1 (L-R): Signatories: Mr. Mazen Darwazah, Executive Vice Chairman & President of MENA - Hikma Pharmaceuticals and Dr. Fahed Al Marzooqi, CEO of Integrated Health Solutions Platform, M42. Witnesses: Dr. Sherif Shafick, Vice President of Hospital Business, MENA – Hikma Pharmaceuticals and Mr. Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42. Picture 2 (L-R): Dr. Sherif Shafick, Vice President of Hospital Business, MENA – Hikma Pharmaceuticals, Mr. Mazen Darwazah, Executive Vice Chairman & President of MENA – Hikma Pharmaceuticals, Mr. Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42 and Dr. Fahed Al Marzooqi, CEO of Integrated Health Solutions Platform, M42.

Meet Nika Beck, Manufacturing Specialist at Hikma 503B, and discover how she champions quality to put better health within reach, every day at #hikma Learn more: https://brnw.ch/21wQh7o #DistinctlyHikmaQuality #Quality #MeetOurTeam #BetterHealth #HikmaUS

Discover our #Hikma #Manufacturing #Footprint. Our plant in #Goslar, #Germany, serves as a hub for liquid and lyophilisation cytotoxic production for the US, Europe, and MENA. We leverage our extensive high-quality manufacturing capabilities to supply medicines and make a meaningful impact in the communities we serve. Read more about our expertise: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #Europe #Injectables

On #InternationalDayofEducation, we reaffirm our commitment to education as a key part of our sustainability agenda. Providing educational programmes is a priority in our corporate social responsibility efforts. We collaborate with universities, schools, and community organisations to offer better learning opportunities, essential supplies, and classroom renovations. #Health #Wellbeing #Education #Hikma #Sustainability Read more: https://brnw.ch/21wQdtP

Discover our #Hikma #Manufacturing #Footprint. Our #Sintra, #Portugal site is the global hub for our Injectables business. It has three plants with complex manufacturing technologies and the ability to produce general formulations, high containment products and cephalosporins. With over 900 employees, this site has been meeting our evolving customer needs in the US, EU, and MENA for over 35 years. We leverage our extensive high-quality manufacturing capabilities to supply medicines and make a meaningful impact in the communities we serve. Read more about our expertise: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #Europe #Healthcare #Injectables

Discover our #HikmaFootprint. For over 30 years, Hikma #Algeria has been supporting healthcare needs of patients in the country with a diversified portfolio of medicines covering eight therapeutic areas to address a wide range of healthcare needs. Operating four manufacturing plants we are investing in building more local capabilities to continue to improve access to essential medicine. We leverage our extensive high-quality manufacturing capabilities to supply medicines and make a meaningful impact in the local communities we serve. Read more: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #MENA

Discover our #HikmaFootprint. Our #Cherry Hill, NJ site in the #US produces injectable medicines of various strengths and dosage forms, including prefilled syringes. We have more than 600 dedicated employees who work diligently to ensure an uninterrupted supply of essential medicines that hospitals, physicians, and pharmacists rely on to treat patients. We leverage our extensive high-quality manufacturing capabilities and global reach to deliver meaningful impact in the communities we serve. Read more about our local expertise: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #NewJersey #Injectables #Prefilled

Discover our #HikmaFootprint. Founded in #Jordan, Hikma has been putting better health within reach, for over 45 years. Operating five manufacturing plants with over 2,000 empowered employees, we are the largest pharmaceutical company by sales in the country [1]. We leverage our extensive high-quality manufacturing capabilities to supply medicines and make a meaningful impact in the local communities we serve. Read more: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #MENA #Healthcare [1] Based on internal analysis by Hikma Pharmaceuticals PLC using data from the following source: IQVIA MIDAS® Quarterly value sales data for the countries listed below for the period :MAT Aug. 2024 , Market definitions: Includes all therapeutic areas except for those ATC-3 classes that may encompass Nutrients, Infant Formulas, and Diagnostics elements within MIDAS Data, specifically ATCs S1T, T1G, T2X, T3A, V6C, and V6D, in each case reflecting estimates of real-world activity. Copyright IQVIA. All rights reserved.

News for #Investors and #Media. Listen to Riad Mishlawi, #Hikma CEO today at 15:00 PST | 23:00 GMT speaking live at #JPM25. Tune in here via the JPM25 link here https://brnw.ch/21wPXEq Access the presentation here: https://lnkd.in/dnkjf3jJ

Discover our #HikmaFootprint. At our #Columbus, Ohio site in the #US, we have two state-of-the-art manufacturing plants with capabilities to manufacture a wide range of non-injectable products, including inhalation and nasal sprays, where we are the largest supplier by volume [1]. We leverage our extensive high-quality manufacturing capabilities to supply medicines and make a meaningful impact in the local communities we serve. Read more: https://lnkd.in/dC7_Dp4B [1] IQVIA MAT November 2024). #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #Ohio #GenericPharmaceuticals